Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label randomized study of rifaximin plus fiber for prevention of recurrent diverticulitis
2006-006157-27Phase 4Completed
- Sponsor
- Bama-Geve
- Start
- Mar 2007
- Modality
- Small Molecules, Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of rifaximin and psyllium husks in diverticular disease and diverticulitis (2 arms), sponsored by Bama-Geve. Started Mar 2007; status: completed.
02
Drugs
rifaximinpsyllium husks
03
Conditions
diverticular diseasediverticulitis
Beyond the preview
Go deeper on 2006-006157-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006157-27.